JPMorgan Starts Idenix Pharmaceuticals Inc. (IDIX) at Overweight
Tweet Send to a FriendGet Alerts IDIX Hot Sheet
Price: $4.24 +1.19%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Trade IDIX Now!
JPMorgan initiates coverage on Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) with an Overweight. PT $12.00.
For more ratings news on Idenix Pharmaceuticals Inc. click here and for the rating history of Idenix Pharmaceuticals Inc. click here.
Shares of Idenix Pharmaceuticals Inc. closed at $6.34 yesterday, with a 52 week range of $2.57-$6.45.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Idenix Pharmaceuticals Inc. click here and for the rating history of Idenix Pharmaceuticals Inc. click here.
Shares of Idenix Pharmaceuticals Inc. closed at $6.34 yesterday, with a 52 week range of $2.57-$6.45.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Starts Alnylam Pharmaceuticals (ALNY) at Buy
- Topeka Capital Starts RDA Microelectronics (RDA) at Buy
- Dollar Tree (DLTR) Beats But Looks Stretched - Jefferies
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
JPMorgan
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
